$4.53
0.89% day before yesterday
Nasdaq, Jul 11, 10:00 pm CET
ISIN
US50015M1099
Symbol
KOD
Sector
Industry

Kodiak Sciences, Inc. Stock price

$4.53
+0.50 12.41% 1M
-3.28 42.00% 6M
-5.42 54.47% YTD
+1.77 64.13% 1Y
-4.19 48.05% 3Y
-44.02 90.67% 5Y
-5.63 55.41% 10Y
-5.63 55.41% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
+0.04 0.89%
ISIN
US50015M1099
Symbol
KOD
Sector
Industry

Key metrics

Basic
Market capitalization
$239.0m
Enterprise Value
$100.2m
Net debt
positive
Cash
$138.9m
Shares outstanding
52.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
2.2
Financial Health
Equity Ratio
44.8%
Return on Equity
-117.3%
ROCE
-74.1%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-169.2m | $-214.5m
EBIT
$-198.0m | $-236.1m
Net Income
$-190.6m | $-211.8m
Free Cash Flow
$-107.4m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
26.3% | -33.9%
EBIT
20.4% | -26.4%
Net Income
18.1% | -20.2%
Free Cash Flow
38.9%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-3.6
FCF per Share
$-2.0
Short interest
6.3%
Employees
109
Rev per Employee
$0.0
Show more

Is Kodiak Sciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Kodiak Sciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Kodiak Sciences, Inc. forecast:

1x Buy
8%
3x Hold
25%
8x Sell
67%

Analyst Opinions

12 Analysts have issued a Kodiak Sciences, Inc. forecast:

Buy
8%
Hold
25%
Sell
67%

Financial data from Kodiak Sciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 58 58
16% 16%
-
- Research and Development Expense 140 140
22% 22%
-
-169 -169
26% 26%
-
- Depreciation and Amortization 29 29
50% 50%
-
EBIT (Operating Income) EBIT -198 -198
20% 20%
-
Net Profit -191 -191
18% 18%
-

In millions USD.

Don't miss a Thing! We will send you all news about Kodiak Sciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kodiak Sciences, Inc. Stock News

Neutral
PRNewsWire
3 days ago
PALO ALTO, Calif.  , July 10, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing, and commercializing transformative therapeutics, announced today it will host an investor R&D Day webcast on Wednesday, July 16, 2025, from 4:00 pm ET to 5:30 pm ET.
Neutral
PRNewsWire
17 days ago
PALO ALTO, Calif. , June 25, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that management along with key opinion leaders will present KSI-101 highlights at the 2025 Congress of the International Ocular Inflamm...
Neutral
PRNewsWire
about one month ago
PALO ALTO, Calif. , May 29, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that Victor Perlroth, M.D.
More Kodiak Sciences, Inc. News

Company Profile

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD; and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Head office United States
CEO Victor Perlroth
Employees 109
Founded 2009
Website kodiak.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today